TLN-232

· Thallion Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLN-232, covering 2010-08-05 to 2010-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma [Phase 2]